| Protein-based nanoparticles as drug delivery systems S Hong, DW Choi, HN Kim, CG Park, W Lee, HH Park Pharmaceutics 12 (7), 604, 2020 | 457 | 2020 |
| COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm W Lee, JH Ahn, HH Park, HN Kim, H Kim, Y Yoo, H Shin, KS Hong, ... Signal transduction and targeted therapy 5 (1), 186, 2020 | 139 | 2020 |
| Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm YY Lee, HH Park, W Park, H Kim, JG Jang, KS Hong, JY Lee, HS Seo, ... Biomaterials 267, 120389, 2021 | 131 | 2021 |
| Nanocomplex‐mediated in vivo programming to chimeric antigen receptor‐M1 macrophages for cancer therapy M Kang, SH Lee, M Kwon, J Byun, D Kim, C Kim, S Koo, SP Kwon, ... Advanced materials 33 (43), 2103258, 2021 | 129 | 2021 |
| Bioinspired DNase‐I‐coated melanin‐like nanospheres for modulation of infection‐associated NETosis dysregulation HH Park, W Park, YY Lee, H Kim, HS Seo, DW Choi, HK Kwon, DH Na, ... Advanced Science 7 (23), 2001940, 2020 | 77 | 2020 |
| Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles HJ Lee, HH Park, JA Kim, JH Park, J Ryu, J Choi, J Lee, WJ Rhee, ... Biomaterials 35 (5), 1696-1704, 2014 | 71 | 2014 |
| Enhancement of recombinant human EPO production and sialylation in chinese hamster ovary cells through Bombyx mori 30Kc19 gene expression Z Wang, JH Park, HH Park, W Tan, TH Park Biotechnology and bioengineering 108 (7), 1634-1642, 2011 | 64 | 2011 |
| Evaluation of the anti-oxidative and ROS scavenging properties of biomaterials coated with epigallocatechin gallate for tissue engineering S Lee, J Lee, H Byun, S Kim, J Joo, HH Park Acta Biomaterialia 124, 166-178, 2021 | 63 | 2021 |
| A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm JH Park, JH Lee, HH Park, WJ Rhee, SS Choi, TH Park Biomaterials 33 (35), 9127-9134, 2012 | 63 | 2012 |
| Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19 JH Park, Z Wang, HJ Jeong, HH Park, BG Kim, WS Tan, SS Choi, TH Park Applied microbiology and biotechnology 96, 671-683, 2012 | 47 | 2012 |
| PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses HH Park, H Kim, HS Lee, EU Seo, JE Kim, JH Lee, YH Mun, SY Yoo, J An, ... Biomaterials 273, 120827, 2021 | 45 | 2021 |
| Stem cell-derived exosomes and nanovesicles: promotion of cell proliferation, migration, and anti-senescence for treatment of wound damage and skin ageing H Cha, S Hong, JH Park, HH Park Pharmaceutics 12 (12), 1135, 2020 | 41 | 2020 |
| Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients EY Choi, HH Park, H Kim, HN Kim, I Kim, S Jeon, W Kim, JS Bae, W Lee European Respiratory Journal 56 (5), 2020 | 41 | 2020 |
| Beneficial effect of 30Kc6 gene expression on production of recombinant interferon-β in serum-free suspension culture of CHO cells TY Koo, JH Park, HH Park, TH Park Process Biochemistry 44 (2), 146-153, 2009 | 40 | 2009 |
| Protein‐stabilizing and cell‐penetrating properties of α‐helix domain of 30Kc19 protein J Ryu, H Kim, HH Park, HJ Lee, JH Park, WJ Rhee, TH Park Biotechnology journal 11 (11), 1443-1451, 2016 | 39 | 2016 |
| Stabilization of enzymes by the recombinant 30Kc19 protein JH Park, HH Park, SS Choi, TH Park Process biochemistry 47 (1), 164-169, 2012 | 39 | 2012 |
| Identification and characterization of a novel cell-penetrating peptide of 30Kc19 protein derived from Bombyx mori HH Park, Y Sohn, JW Yeo, JH Park, HJ Lee, J Ryu, WJ Rhee, TH Park Process biochemistry 49 (9), 1516-1526, 2014 | 38 | 2014 |
| Efficient encapsulation and sustained release of basic fibroblast growth factor in nanofilm: extension of the feeding cycle of human induced pluripotent stem cell culture U Han, HH Park, YJ Kim, TH Park, JH Park, J Hong ACS applied materials & interfaces 9 (30), 25087-25097, 2017 | 31 | 2017 |
| α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease HJ Lee, HH Park, Y Sohn, J Ryu, JH Park, WJ Rhee, TH Park Applied microbiology and biotechnology 100, 10395-10402, 2016 | 31 | 2016 |
| Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm H Kim, HS Lee, JH Ahn, KS Hong, JG Jang, J An, YH Mun, SY Yoo, ... Nano Today 38, 101149, 2021 | 29 | 2021 |
